Medila Pharmaceuticals Private Limited
About Medila Pharmaceuticals Private Limited
Data last updated:
Medila Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 24 January 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100DL2014PTC263976. Its GSTIN is 10AAJCM0943L1ZL (Bihar).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ravi Prakash and Anaagat.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at O – 29 Block – O F/F Vijay Vihar, Delhi, India – 110059.
As per the financials filed for FY 2020, the company reported a revenue of ₹1.45 Lakh, a decline of 51% compared to the previous year. For the same year it recorded a net loss of ₹59,047 (net margin -40.8%) and EBITDA of ₹21,758 (EBITDA margin 15%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Medila Pharmaceuticals Private Limited's registered office is in Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressO – 29 Block – O F/F Vijay Vihar, Delhi, India – 110059
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Medila Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Medila Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Medila Pharmaceuticals Private Limited, buy the company report.
Financials of Medila Pharmaceuticals Private Limited
FY 2023 filings availableMedila Pharmaceuticals Private Limited reported revenue of ₹1.45 Lakh (down 51% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue fell 51% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹1.45 Lakh | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹21,758 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹59,047 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15% | ||||
| Net Profit Margin | -40.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medila Pharmaceuticals Private Limited, buy the company report.
Board of directors of Medila Pharmaceuticals Private Limited
Medila Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ravi Prakash | Director | 24 Jan 2014 | 12 Years 9 Months | Current |
| Anaagat | Director | 24 Jan 2014 | 12 Years 9 Months | Current |
Shareholding
The shareholding of Medila Pharmaceuticals Private Limited is on record for FY 2016, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2016 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Medila Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Medila Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medila Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Medila Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAJCM0943L1ZL | Bihar | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Medila Pharmaceuticals Private Limited, buy the company report.
Recent activity
Medila Pharmaceuticals Private Limited has 2 board changes on record since 2014: 2 appointments. The latest: Anaagat was appointed as Director on 24 Jan 2014.
Frequently asked questions
Medila Pharmaceuticals is an active private limited company based in Delhi, India. The company works in other wholesale, within the trading industry. It was incorporated on 24 January 2014 (12+ years old) and is registered under CIN U24100DL2014PTC263976.
Medila Pharmaceuticals has 2 current directors:
- Ravi Prakash - Director
- Anaagat - Director
The latest financial statements of Medila Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from 2015 are in the company report.
The GSTIN of Medila Pharmaceuticals is 10AAJCM0943L1ZL, registered in Bihar.
The CIN (Corporate Identification Number) of Medila Pharmaceuticals is U24100DL2014PTC263976. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medila Pharmaceuticals was incorporated on 24 January 2014, making it 12+ years old. It is registered with the Registrar of Companies, Delhi.
Anaagat was appointed as Director on 24 Jan 2014. Ravi Prakash was appointed as Director on 24 Jan 2014.
The registered office of Medila Pharmaceuticals is at O – 29 Block – O FF Vijay Vihar, Delhi, India – 110059.
Medila Pharmaceuticals operates in the trading industry, in the other wholesale segment.
The compliance status of Medila Pharmaceuticals is compliant as of 03 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
